Assessing the effectiveness of the prescription drug post-market surveillance system in Canada
Subtitle: he need for a more active regulatory role.
Published: 2005
Language: eng
Number of pages: 73
Description: Prescription drugs are becoming an increasingly important component of health care in Canada. Therefore, it is important for regulators such as Health Canada to effectively protect the public from the risks of taking prescription medicines. This thesis will begin by summarizing the inherent safety limitations of the drug development process and the history behind the formation of an internationally acceptable post-market monitoring system. It will then analyze the current spontaneous reporting program operated by Health Canada, highlighting procedural and substantive problems that limit the overall effectiveness of the passive post-market surveillance system. The author concludes by exploring new measures that Health Canada can adopt to make the post-marketing surveillance system more active and structured. In particular, the author emphasizes the need to establish an Independent National Drug Agency to reduce conflict of interest in the decision-making process.
Notes: Source: Masters Abstracts International, Volume: 44-02, page: 0686.

Thesis (LL.M.)--University of Toronto, 2005.

Electronic version licensed for access by U. of T. users.

ROBARTS MICROTEXT copy on microfiche (1 microfiche).